跳转到主要内容
搜索

监管审批

注册

最新资源

精选资源

Upcoming regulatory webinars

网络研讨会

革新传统 NCA 流程：ADNCA 技术助力合规化药代动力学分析

2025 年 7 月 9 日 – 11am（美东时间）
网络研讨会

AI 驱动云平台革新 PK/PD 工作流程

2025 年 7 月 10 日 – 11am（美东时间）
网络研讨会

加速源数据到 SDTM 标准的映射进程

July 15 – 11am ET & July 17 – 11am IST

Latest regulatory blogs

在以下活动中与我们的专家会面

会议

ISSX 2025 International Meeting

2025 年 9 月 12 - 14 日，伊利诺伊州芝加哥市
会议

ACoP 2025

2025 年 10 月 18 - 21 日

All regulatory resources

Pirana 技巧与窍门 — Pirana 中的报告对象生成

Certara 产品，网络研讨会

5 大临床开发挑战 — 基于模型的荟萃分析（MBMA）助力应对

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Blog

Define.xml 递交的 Do’s 与 Don’ts

CDISC, Certara Products - Pinnacle 21, Define-XML, Blog

如何通过模型引导的药物开发助力项目从高风险局面中脱困

Certara Services, Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Case Study

提升医药研发效率，从数据出发

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Press Coverage

FDA ESG NextGen 助力监管申报

Certara Products - GlobalSubmit, Blog

建模与模拟及真实世界证据在临床试验多样性规划中的关键作用：挑战应对策略

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

从数据到决策：基于模型的荟萃分析（MBMA）与 GSK 和 Certara 真实世界影响

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar

加速源数据到 SDTM 标准的映射进程

Certara Products - Pinnacle 21, Webinar

革新传统 NCA 流程：ADNCA 技术助力合规化药代动力学分析

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Webinar - Resources LP - Upcoming, Webinar

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

Cardiovascular, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

AI 驱动云平台革新 PK/PD 工作流程

Certara Products - Phoenix, Webinar - Resources LP - Upcoming, Webinar
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software